Skip to content
Rival
Models
CompareBest ForArena
Sign Up
Sign Up

Compare AI vibes, not scores. Side-by-side outputs across the world's best models.

@rival_tips

Explore

  • Compare Models
  • All Models
  • Leaderboard
  • Challenges

Discover

  • AI Creators
  • AI Tools
  • The Graveyard

Developers

  • Developer Hub
  • MCP Server
  • .llmignore
  • Badges
  • RIVAL Datasets

Connect

  • Methodology
  • Sponsor
  • Partnerships
  • Privacy Policy
  • Terms
  • RSS Feed
© 2026 Rival
Rival
Models
CompareBest ForArena
Sign Up
Sign Up

Compare AI vibes, not scores. Side-by-side outputs across the world's best models.

@rival_tips

Explore

  • Compare Models
  • All Models
  • Leaderboard
  • Challenges

Discover

  • AI Creators
  • AI Tools
  • The Graveyard

Developers

  • Developer Hub
  • MCP Server
  • .llmignore
  • Badges
  • RIVAL Datasets

Connect

  • Methodology
  • Sponsor
  • Partnerships
  • Privacy Policy
  • Terms
  • RSS Feed
© 2026 Rival
  1. Home
  2. Models
  3. GPT-4o (Omni)
  4. Ethical Dilemma with Stakeholders

See how GPT-4o (Omni) compares on this challenge:

  • GPT-4o (Omni) vs Claude Sonnet 4.6
  • GPT-4o (Omni) vs Gemini 3.1 Pro Preview
  • GPT-4o (Omni) vs Z.ai: GLM 5

4 models have responded to the "Ethical Dilemma with Stakeholders" challenge. Compare their approaches side-by-side on RIVAL. This response is part of RIVAL's open dataset of 5,600+ AI model responses.

Rival
Models
CompareBest ForArena
Sign Up
Sign Up
Back to GPT-4o (Omni)

Ethical Dilemma with Stakeholders

Gpt 4O's response to the 'Ethical Dilemma with Stakeholders' challenge.

GPT-4o (Omni)
February 3, 2026
Text

?
Prompt

You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has just been flagged by your internal research team: a rare but serious side effect (liver failure in approximately 1 in 8,000 patients over 5 years) was missed in clinical trials and is not in the current warnings. Your legal team says formal regulatory reporting would take 6 months. Your stock price would likely drop 40% on disclosure. Three board members are pushing to "wait for more data." You have a board meeting in 48 hours and a scheduled earnings call in 72 hours. What do you do in the next 48 hours? Provide a specific, hour-by-hour action plan. Consider legal liability, ethical obligations, financial implications, PR strategy, patient safety, employee morale, and regulatory relationships. Explain the reasoning behind each decision.

GPT-4o (Omni)
Response

gpt-4o logo
GPT-4o (Omni)Ethical Dilemma with Stakeholders
gpt-4o logo
GPT-4o (Omni)

Day 1

Hour 1-2: Immediate Assessment and Information Gathering

  • Objective: Gather all available data on the side effect, including the internal research report, patient case studies, and any existing literature.
  • Reasoning: A comprehensive understanding of the situation is crucial for informed decision-making.

Hour 3-4: Assemble a Crisis Management Team

  • Objective: Form a cross-functional team including legal, compliance, R&D, communications, and operations.
  • Reasoning: A multidisciplinary approach ensures that all aspects of the issue are considered.

Hour 5-6: Legal and Ethical Review

  • Objective: Consult with the legal team to understand the implications of immediate disclosure vs. waiting for more data.
  • Reasoning: Balance legal obligations with ethical responsibilities to patients and shareholders.

Hour 7-8: Develop Preliminary Communication Strategy

  • Objective: Work with PR and communications to draft internal and external messages. Prepare for potential media inquiries.
  • Reasoning: Transparent communication can help manage public perception and maintain trust.

Hour 9-10: Board Member Briefing

  • Objective: Conduct a briefing with board members to update them on the situation and outline the proposed action plan.
  • Reasoning: Ensure alignment and prepare for the upcoming board meeting.

Hour 11-12: Consult Key Stakeholders

  • Objective: Speak with key opinion leaders in the medical community and patient advocacy groups to gauge their perspectives.
  • Reasoning: External insights can guide the decision-making process and enhance credibility.

Day 2

Hour 13-14: Scenario Planning and Risk Assessment

  • Objective: Conduct a risk assessment for different scenarios, including immediate disclosure, waiting for more data, and potential regulatory responses.
  • Reasoning: Anticipate the outcomes of each scenario to make a well-informed decision.

Hour 15-16: Draft Contingency Plans

  • Objective: Prepare plans for dealing with potential fallout, including stock price impact, regulatory actions, and lawsuits.
  • Reasoning: Being prepared can mitigate the impact of negative outcomes.

Hour 17-18: Finalize Board Meeting Presentation

  • Objective: Prepare a presentation for the board meeting, including data, risks, and proposed actions.
  • Reasoning: A clear presentation will facilitate decision-making and ensure all board members are informed.

Hour 19-20: Board Meeting Preparation

  • Objective: Rehearse the presentation and anticipate board member questions and concerns.
  • Reasoning: Being well-prepared enhances the credibility and effectiveness of the presentation.

Hour 21-22: Internal Communication

  • Objective: Brief senior management and department heads to ensure they are informed and aligned.
  • Reasoning: Consistent messaging across the company is crucial for maintaining employee morale and trust.

Hour 23-24: Board Meeting

  • Objective: Present the situation, proposed actions, and seek board approval for the chosen course of action.
  • Reasoning: The board's buy-in is essential for any significant decision affecting the company.

Next Steps Post-Board Meeting

  • Immediate Disclosure: If the decision is to disclose immediately, prepare an official statement for regulatory bodies, investors, and the public. Update product warnings and inform healthcare professionals.
  • Wait for More Data: If the decision is to wait, set a timeline for data collection and reassessment. Communicate the plan internally to maintain trust and transparency.
  • Earnings Call Preparation: Adapt the earnings call script to address the issue honestly, focusing on the company's commitment to patient safety and regulatory compliance.

Considerations

  • Legal Liability: Ensure that all actions comply with legal obligations and minimize the risk of future lawsuits.
  • Ethical Obligations: Prioritize patient safety and transparency to maintain ethical standards.
  • Financial Implications: Consider the long-term financial health of the company over short-term stock price fluctuations.
  • PR Strategy: Develop a proactive communication strategy to manage public perception and maintain trust.
  • Employee Morale: Keep employees informed to prevent misinformation and anxiety.
  • Regulatory Relationships: Maintain open communication with regulators to demonstrate responsibility and cooperation.

This plan prioritizes patient safety and transparency while considering the company's legal and financial standing.

Ethical Dilemma with Stakeholders

Turn this model response into notes, narration, or a short video

Auto NotesTranscriptNarrateVideo Cut

Partner link

This output is part of our open dataset — 5K+ AI responses across 200 models

About GPT-4o (Omni)

Capabilities

ConversationReasoningAnalysisCode GenerationImage Generation

Categories

TextVisionMultimodal

Specifications

Provider
Openai
Released
2024-05-13
Size
XLARGE
Parameters
1.8T
Context
128,000 tokens

Keep exploring

SAME PROMPT

Claude Sonnet 4.6's version

Same prompt, different result

COMPARE

GPT-4o (Omni) vs Gemini 3.1 Pro Preview

Both outputs, side by side

Compare AI vibes, not scores. Side-by-side outputs across the world's best models.

@rival_tips

Explore

  • Compare Models
  • All Models
  • Leaderboard
  • Challenges

Discover

  • AI Creators
  • AI Tools
  • The Graveyard

Developers

  • Developer Hub
  • MCP Server
  • .llmignore
  • Badges
  • RIVAL Datasets

Connect

  • Methodology
  • Sponsor
  • Partnerships
  • Privacy Policy
  • Terms
  • RSS Feed
© 2026 Rival